Trace Neuroscience

The 2026 #MDAConference kicks off this weekend! We invite attendees to join preclinical science lead Terry Fang for viewing of our latest posters on our recent #ALS research during breaks on Monday, and at the poster & networking reception at 6PM. We look forward to connecting!

VP, Translational Sciences, Sanjay Chandriani, will speak on employing digital health technology assessments in #ALS trials at #ADDS2026 this afternoon! If you're in ATL for @actigraph's 2026 Digital Data Summit, join us in the Grand Ballroom @ 4:35PM. adds.ametris.com/2026/atlanta/a…

At Trace, 2/3 of our leadership team & over 1/2 of our broader team are women. Today, we celebrate them & all the incredible #WomenInScience and biotech who continue to advance drug development and move meaningful progress forward for people living with ALS and other diseases.♀️

We were excited to join @youralsnetwork at their Research Summit! We value opportunities to connect with the #ALS research community & advocates, and were grateful to share an industry update during the meeting. We look forward to more dialogue on advancing ALS research in 2026.

We're kicking off 2026 at #JPM26! Members of the Trace team @ercgrn, @NMordwinkin, Irina Antonijevic and Vanessa Yang will be in San Francisco and look forward to connecting and discussing our advancement of new approaches for #ALS.

We're thrilled to share we've been named to @BioSpace's NextGen Class of 2026! 1 in 400 people globally will be diagnosed with #ALS in their life. At Trace, we aim to change the fact that a majority will never receive effective treatment for their disease. biospace.com/nextgen

This year-end brings reflection, momentum, and a steady upward pace - all guiding us toward a promising new year at Trace. We closed out 2025 with a cheery holiday celebration and look forward to all that #2026 has to offer. Happy New Year!

It was so special to welcome John Peffer to Trace. John was diagnosed with #ALS last year & is now a full-time advocate & fundraiser for ALS research. We admire his use of humor & positivity to raise awareness for ALS, primarily on his #TikTok: @johnpeffer2/video/7585262743138225463" target="_blank" rel="nofollow noopener">tiktok.com/@johnpeffer2/v…

It was energizing to connect with folks in the #ALS/#MND community this weekend at the annual #ALSMNDSymp! We're humbled & grateful to be part of this dedicated, innovative community. It takes a village to deliver new treatments for neurodegenerative diseases to patients in need.

Trace leaders are looking forward to sharing updates during the #ALSMNDSymp! Join us for an oral presentation on our lead development candidate, TRCN-1023, and three posters on our innovation in #ALS clinical trials throughout the weekend. Learn more below.

We loved spending time with David Buseck & Linda Levine, learning how they approach life with #ALS with positivity and purpose. Their adventurous spirit and resilience left us truly inspired. Visit their websites: SurpriseEnterprise.com DavidBuseck.com

1 in 400 people will be diagnosed with ALS in their lifetime. A year ago, we launched Trace Neuroscience to expand the promise of genetic medicine for all people with #ALS. We're grateful to continue driving our vision forward alongside the ALS community and our incredible team.

As @FierceBiotech put it, this year's #Fierce15 share one main common thread: "they're all challenging old ways of working." We were privileged to celebrate with our fellow 2025 honorees last night. We're proud to be recognized as leaders in next-gen biotech innovation.

We're headed to #NEALS2025 this week and look forward to connecting with our #ALSResearch community. Join us at our lightning talk and posters throughout the week. Details below.

On Saturday, we joined @ALSNetwork for their Ride, Walk & Roll to #CureALS! The exceptional families, caretakers & individuals impacted by ALS who come together for this event are inspiring. We're honored to play a small part in advancing research for this life-altering disease.

We are humbled to be named as one of the best in biotech on the 2025 #Fierce15. We're proud of our fierce dedication to revolutionizing therapy options for those living with #ALS. This recognition is a testament to what's ahead for Trace. List: fiercebiotech.com/special-report…

Today, we heard from John & Nancy Frates, parents of Pete Frates, who was diagnosed with #ALS in 2012 & led the ALS Ice Bucket Challenge, a viral movement that forever changed the fight against ALS. They continue support the fight & honor Pete's legacy through the @PF3Foundation.

SVP, Development Sciences, Marjie Hard, will share our recent work in Advancing a Splice-Modulating ASO Restoring UNC13A protein for #ALS during this week's Oligonucleotides for CNS Summit in Boston. Join us for her session on Friday! oligonucleotides-cns.com/whats-on/full-…

CMO Irina Antonijevic looks forward to joining @ALSTDI & Alexandria Real Estate Center for Life Science during Last Nerve, an event focused on innovation in #ALS research through the lens of advocate and author @MindyUhrlaub's new book. Details here. events.are.com/lastnerve20252

This week, we are excited to present a poster on preclinical data from our lead ASO development candidate, TRCN-1023, and the Phase 1/2 clinical trial outline at #ALSNexus. The poster will be presented by CMO Irina Antonijevic on Wednesday evening's poster session, 4-6:30PM CDT.